NT-proBNP对老年瓣膜性心脏病患者的预后价值
该研究纳入5983例年龄≥60岁的中重度瓣膜性心脏病患者,行超声心动图和NT-proBNP检测,随访1年死亡561例(9.4%);NT-proBNP比值升高与死亡独立相关(总体校正HR 1.99,95%CI 1.76–2.24,P<0.001),以主动脉瓣狭窄关联最强(校正HR 10.5,95%CI 3.9–28.27,P<0.001),加入NT-proBNP比值可改善预后预测。
要点
- NT-proBNP比值升高与老年瓣膜性心脏病患者死亡风险独立相关。
- 主动脉瓣狭窄患者中NT-proBNP比值与死亡的关联最强。
- 将NT-proBNP比值加入传统风险因素模型可改善预后预测。
核心结论
- NT-proBNP为多种瓣膜性心脏病提供额外的死亡预后信息,可作为老年患者风险分层的实用生物标志物。
研究设计与样本
- 共纳入5983例年龄≥60岁的中重度瓣膜性心脏病患者,行超声心动图和NT-proBNP检测。
- 检查的瓣膜病包括主动脉瓣狭窄、主动脉瓣反流、二尖瓣狭窄、二尖瓣反流、三尖瓣反流和多瓣膜心脏病。
- NT-proBNP比值定义为实测NT-proBNP相对于年龄和性别特异性最大正常值的比值,疾病特异性阈值基于惩罚样条和最大选择秩统计量确定。
主要发现
- 队列平均年龄71.1±7.6岁,1年随访期间发生561例死亡(9.4%)。
- 惩罚样条分析显示,除二尖瓣狭窄外,不同瓣膜病中NT-proBNP比值越高,死亡相对风险呈单调增加(所有P<0.001)。
- 按疾病特异性阈值分类,较高NT-proBNP比值与死亡独立相关(总体校正HR 1.99,95%CI 1.76–2.24,P<0.001)。
- 不同亚型瓣膜病中NT-proBNP比值升高均与超额死亡相关,以主动脉瓣狭窄关联最强(校正HR 10.5,95%CI 3.9–28.27,P<0.001)。
- 将NT-proBNP比值加入包含传统风险因素的预测算法可改善结局预测(总体NRI=0.28,95%CI 0.24–0.34,P<0.001;似然比检验P<0.001)。
关键数值与推荐
- 总体校正HR 1.99(95%CI 1.76–2.24,P<0.001)对应按疾病特异性阈值分类的较高NT-proBNP比值与死亡的独立关联。
- 主动脉瓣狭窄亚组校正HR 10.5(95%CI 3.9–28.27,P<0.001)。
- 总体NRI=0.28(95%CI 0.24–0.34,P<0.001),似然比检验P<0.001。
临床怎么用
- 在老年中重度瓣膜性心脏病患者中,可检测NT-proBNP比值辅助风险分层。
- NT-proBNP比值升高提示死亡风险增加,尤其主动脉瓣狭窄患者应关注。
- 可将NT-proBNP比值纳入传统风险因素模型以改善预后预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: N-terminal pro-B-type natriuretic peptide (NT-proBNP) may reflect early prognosis in patients with valvular heart disease (VHD). OBJECTIVES: The aim of this study was to examine the association between NT-proBNP and mortality in elderly patients with VHD. METHODS: A total of 5,983 elderly patients (age ≥60 years) with moderate or severe VHD underwent echocardiography and NT-proBNP measurement. VHD examined included aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation, tricuspid regurgitation, and multivalvular heart disease. NT-proBNP ratio was defined as measured NT-proBNP relative to the maximal normal values specific to age and sex. Disease-specific thresholds were defined on the basis of penalized splines and maximally selected rank statistics. RESULTS: The cohort had a mean age of 71.1 ± 7.6 years. At 1-year follow-up, 561 deaths (9.4%) had occurred. In penalized splines, relative hazards showed a monotonic increase with greater NT-proBNP ratio for death with different VHDs (p < 0.001 for all) except mitral stenosis. Higher NT-proBNP ratio, categorized by disease-specific thresholds, was independently associated with mortality (overall adjusted hazard ratio: 1.99; 95% confidence interval: 1.76 to 2.24; p < 0.001). Different subtypes of VHD all incurred excess mortality with elevated NT-proBNP ratio, with the strongest association detected for aortic stenosis (adjusted hazard ratio: 10.5; 95% confidence interval: 3.9 to 28.27; p < 0.001). The addition of NT-proBNP ratio to the prediction algorithm including traditional risk factors improved outcome prediction (overall net reclassification index = 0.28; 95% CI: 0.24 to 0.34; p < 0.001; likelihood ratio test p < 0.001). Results remained consistent in patients under medical care, with normal left ventricular ejection fractions, and with primary VHD. CONCLUSIONS: NT-proBNP provides incremental prognostic information for mortality in various VHDs. It could aid in risk stratification as a pragmatic and versatile biomarker in elderly patients.
引用
- Zhang B, Xu H, Zhang H, et al. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease. J Am Coll Cardiol. 2020. PMID: 32273031. doi:10.1016/j.jacc.2020.02.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。